Unilever’s bid for GSK’s Consumer HealthCare division is causing a stir, as it seems totally unreasonable. The group was asked to move on portfolio rotation, but definitely not to be so ambitious at the risk of penalising shareholders.
17 Jan 2022
GSK's Consumer HealthCare - why not, but not at this price
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
GSK's Consumer HealthCare - why not, but not at this price
Unilever PLC (ULVR:LON) | 3,975 0 0.0% | Mkt Cap: 99,586m
- Published:
17 Jan 2022 -
Author:
Laura Parisot -
Pages:
3
Unilever’s bid for GSK’s Consumer HealthCare division is causing a stir, as it seems totally unreasonable. The group was asked to move on portfolio rotation, but definitely not to be so ambitious at the risk of penalising shareholders.